SIMILAR PATTERNS OF AMINO ACIDS FOR 2F8G_B_017B401_2
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1a6d | THERMOSOME (BETASUBUNIT) (Thermoplasmaacidophilum) |
PF00118(Cpn60_TCP1) | 5 | LEU B 449ALA B 413GLY B 499VAL B 498ILE B 445 | None | 0.80A | 2f8gB-1a6dB:undetectable | 2f8gB-1a6dB:11.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1azz | COLLAGENASE (Leptucapugilator) |
PF00089(Trypsin) | 5 | ASP A 37GLY A 61ALA A 61ASP A 60ILE A 35 | None | 0.90A | 2f8gB-1azzA:undetectable | 2f8gB-1azzA:18.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1bou | 4,5-DIOXYGENASE BETACHAIN (Sphingomonaspaucimobilis) |
PF02900(LigB) | 5 | GLY B 274ALA B 275ILE B 8GLY B 189VAL B 131 | None | 0.82A | 2f8gB-1bouB:undetectable | 2f8gB-1bouB:14.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1czi | CHYMOSIN (Bos taurus) |
PF00026(Asp) | 5 | ASP E 215GLY E 217VAL E 222GLY E 76ILE E 300 | None | 0.77A | 2f8gB-1cziE:6.7 | 2f8gB-1cziE:17.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ee2 | ALCOHOLDEHYDROGENASE (Equus caballus) |
PF00107(ADH_zinc_N)PF08240(ADH_N) | 6 | GLY A 71ALA A 70VAL A 168PRO A 328VAL A 327ILE A 90 | None | 1.48A | 2f8gB-1ee2A:undetectable | 2f8gB-1ee2A:14.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fxj | UDP-N-ACETYLGLUCOSAMINEPYROPHOSPHORYLASE (Escherichiacoli) |
PF00132(Hexapep)PF12804(NTP_transf_3) | 5 | LEU A 133GLY A 138ILE A 152VAL A 131ILE A 168 | LEU A 133 ( 0.6A)GLY A 138 ( 0.0A)ILE A 152 ( 0.7A)VAL A 131 ( 0.6A)ILE A 168 ( 0.6A) | 0.92A | 2f8gB-1fxjA:undetectable | 2f8gB-1fxjA:16.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ga8 | GALACTOSYLTRANSFERASE LGTC (Neisseriameningitidis) |
PF01501(Glyco_transf_8) | 5 | LEU A 157ASP A 2VAL A 4ILE A 93GLY A 90 | None | 0.92A | 2f8gB-1ga8A:undetectable | 2f8gB-1ga8A:13.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gpe | PROTEIN (GLUCOSEOXIDASE) (Penicilliumamagasakiense) |
PF00732(GMC_oxred_N)PF05199(GMC_oxred_C) | 6 | LEU A 52GLY A 31ALA A 30VAL A 289VAL A 283ILE A 28 | NoneFAD A 600 (-3.2A)FAD A 600 ( 4.8A)NoneNoneNone | 1.27A | 2f8gB-1gpeA:undetectable | 2f8gB-1gpeA:10.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ASP A 25GLY A 27ALA A 28VAL A 32ILE A 50ILE A 84 | A79 A 800 (-2.7A)A79 A 800 (-3.0A)A79 A 800 (-3.1A)A79 A 800 ( 4.4A)A79 A 800 ( 4.0A)A79 A 800 (-3.6A) | 1.28A | 2f8gB-1hvcA:13.9 | 2f8gB-1hvcA:46.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ASP A 25GLY A 27ALA A 28VAL A 32ILE A 50ILE A 84 | A79 A 800 (-2.8A)A79 A 800 (-3.0A)A79 A 800 (-3.2A)A79 A 800 ( 4.3A)A79 A 800 (-3.8A)A79 A 800 (-3.8A) | 1.25A | 2f8gB-1hvcA:13.9 | 2f8gB-1hvcA:46.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | LEU A 23ALA A 28GLY A 48PRO A 81VAL A 82ILE A 84 | A79 A 800 ( 4.0A)A79 A 800 (-3.2A)A79 A 800 (-4.1A)A79 A 800 ( 3.4A)A79 A 800 (-4.5A)A79 A 800 (-3.8A) | 1.06A | 2f8gB-1hvcA:13.9 | 2f8gB-1hvcA:46.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | LEU A 23ASP A 25ALA A 28ASP A 29ILE A 47ILE A 84 | A79 A 800 ( 3.8A)A79 A 800 (-2.7A)A79 A 800 (-3.1A)A79 A 800 (-2.8A)A79 A 800 ( 3.2A)A79 A 800 (-3.6A) | 1.42A | 2f8gB-1hvcA:13.9 | 2f8gB-1hvcA:46.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 10 | LEU A 23ASP A 25GLY A 27ALA A 28ASP A 30VAL A 32ILE A 47PRO A 81VAL A 82ILE A 84 | A79 A 800 ( 3.8A)A79 A 800 (-2.7A)A79 A 800 (-3.0A)A79 A 800 (-3.1A)A79 A 800 ( 4.9A)A79 A 800 ( 4.4A)A79 A 800 ( 3.2A)A79 A 800 ( 3.9A)A79 A 800 (-4.5A)A79 A 800 (-3.6A) | 0.74A | 2f8gB-1hvcA:13.9 | 2f8gB-1hvcA:46.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 10 | LEU A 23ASP A 25GLY A 27ALA A 28ASP A 30VAL A 32ILE A 47PRO A 81VAL A 82ILE A 84 | A79 A 800 ( 4.0A)A79 A 800 (-2.8A)A79 A 800 (-3.0A)A79 A 800 (-3.2A)A79 A 800 ( 4.7A)A79 A 800 ( 4.3A)A79 A 800 ( 3.4A)A79 A 800 ( 3.4A)A79 A 800 (-4.5A)A79 A 800 (-3.8A) | 0.67A | 2f8gB-1hvcA:13.9 | 2f8gB-1hvcA:46.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 10 | LEU A 23ASP A 25GLY A 27ALA A 28VAL A 32ILE A 47GLY A 49PRO A 81VAL A 82ILE A 84 | A79 A 800 ( 3.8A)A79 A 800 (-2.7A)A79 A 800 (-3.0A)A79 A 800 (-3.1A)A79 A 800 ( 4.4A)A79 A 800 ( 3.2A)A79 A 800 ( 3.7A)A79 A 800 ( 3.9A)A79 A 800 (-4.5A)A79 A 800 (-3.6A) | 0.62A | 2f8gB-1hvcA:13.9 | 2f8gB-1hvcA:46.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 10 | LEU A 23ASP A 25GLY A 27ALA A 28VAL A 32ILE A 47GLY A 49PRO A 81VAL A 82ILE A 84 | A79 A 800 ( 4.0A)A79 A 800 (-2.8A)A79 A 800 (-3.0A)A79 A 800 (-3.2A)A79 A 800 ( 4.3A)A79 A 800 ( 3.4A)A79 A 800 (-3.4A)A79 A 800 ( 3.4A)A79 A 800 (-4.5A)A79 A 800 (-3.8A) | 0.50A | 2f8gB-1hvcA:13.9 | 2f8gB-1hvcA:46.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | LEU A 23ASP A 30VAL A 32GLY A 51VAL A 82ILE A 84 | A79 A 800 ( 4.0A)A79 A 800 ( 4.7A)A79 A 800 ( 4.3A)NoneA79 A 800 (-4.5A)A79 A 800 (-3.8A) | 1.19A | 2f8gB-1hvcA:13.9 | 2f8gB-1hvcA:46.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jft | PURINE NUCLEOTIDESYNTHESIS REPRESSOR (Escherichiacoli) |
PF00356(LacI)PF13377(Peripla_BP_3) | 5 | GLY A 253ALA A 254VAL A 243ILE A 233PRO A 185 | None | 0.88A | 2f8gB-1jftA:undetectable | 2f8gB-1jftA:16.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kae | HISTIDINOLDEHYDROGENASE (Escherichiacoli) |
PF00815(Histidinol_dh) | 5 | GLY A 227ALA A 228ASP A 204GLY A 196ILE A 206 | None | 0.91A | 2f8gB-1kaeA:undetectable | 2f8gB-1kaeA:11.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1l3i | PRECORRIN-6YMETHYLTRANSFERASE/PUTATIVE DECARBOXYLASE (Methanothermobacterthermautotrophicus) |
PF13847(Methyltransf_31) | 5 | LEU A 136GLY A 108VAL A 179GLY A 15ILE A 135 | NoneSAH A 801 (-3.4A)NoneSAH A 801 ( 3.8A)None | 0.85A | 2f8gB-1l3iA:undetectable | 2f8gB-1l3iA:20.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1oh9 | ACETYLGLUTAMATEKINASE (Escherichiacoli) |
PF00696(AA_kinase) | 5 | LEU A 176GLY A 173VAL A 39ILE A 133ILE A 6 | None | 0.92A | 2f8gB-1oh9A:undetectable | 2f8gB-1oh9A:17.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1pix | GLUTACONYL-COADECARBOXYLASE ASUBUNIT (Acidaminococcusfermentans) |
PF01039(Carboxyl_trans) | 5 | LEU A 146GLY A 189ALA A 211GLY A 252ILE A 187 | None | 0.84A | 2f8gB-1pixA:undetectable | 2f8gB-1pixA:11.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1q9p | HIV-1 PROTEASE (Homo sapiens) |
PF00077(RVP) | 6 | ASP A 25ALA A 28ASP A 30VAL A 32PRO A 81ILE A 84 | None | 0.77A | 2f8gB-1q9pA:10.1 | 2f8gB-1q9pA:98.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1q9p | HIV-1 PROTEASE (Homo sapiens) |
PF00077(RVP) | 6 | ASP A 25GLY A 27ALA A 28ASP A 30VAL A 32ILE A 84 | None | 0.57A | 2f8gB-1q9pA:10.1 | 2f8gB-1q9pA:98.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qah | PERCHLORIC ACIDSOLUBLE PROTEIN (Rattusnorvegicus) |
PF01042(Ribonuc_L-PSP) | 5 | GLY A 69ALA A 68ILE A 64GLY A 62ILE A 30 | None | 0.88A | 2f8gB-1qahA:undetectable | 2f8gB-1qahA:23.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1siv | SIV PROTEASE (Simianimmunodeficiencyvirus) |
PF00077(RVP) | 6 | LEU A 23ASP A 25GLY A 27ALA A 28ASP A 30PRO A 81 | None | 0.62A | 2f8gB-1sivA:18.5 | 2f8gB-1sivA:50.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1siv | SIV PROTEASE (Simianimmunodeficiencyvirus) |
PF00077(RVP) | 7 | LEU A 23ASP A 25GLY A 27ALA A 28GLY A 49PRO A 81ILE A 84 | None | 0.50A | 2f8gB-1sivA:18.5 | 2f8gB-1sivA:50.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1to3 | PUTATIVE ALDOLASEYIHT (Salmonellaenterica) |
PF01791(DeoC) | 5 | LEU A 184GLY A 188ALA A 189VAL A 127ILE A 158 | None | 0.90A | 2f8gB-1to3A:undetectable | 2f8gB-1to3A:18.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1u3t | ALCOHOLDEHYDROGENASE ALPHACHAIN (Homo sapiens) |
PF00107(ADH_zinc_N)PF08240(ADH_N) | 6 | GLY A 71ALA A 70VAL A 169PRO A 329VAL A 328ILE A 90 | None | 1.43A | 2f8gB-1u3tA:undetectable | 2f8gB-1u3tA:14.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1uio | ADENOSINE DEAMINASE (Mus musculus) |
PF00962(A_deaminase) | 5 | LEU A 231GLY A 203ALA A 204VAL A 165VAL A 213 | None | 0.90A | 2f8gB-1uioA:undetectable | 2f8gB-1uioA:16.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1v5f | PYRUVATE OXIDASE (Aerococcusviridans) |
PF00205(TPP_enzyme_M)PF02775(TPP_enzyme_C)PF02776(TPP_enzyme_N) | 6 | LEU A 276GLY A 215ALA A 214VAL A 236GLY A 222ILE A 212 | NoneFAD A1601 (-2.9A)NoneNoneNoneNone | 1.26A | 2f8gB-1v5fA:undetectable | 2f8gB-1v5fA:10.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vkn | N-ACETYL-GAMMA-GLUTAMYL-PHOSPHATEREDUCTASE (Thermotogamaritima) |
PF01118(Semialdhyde_dh)PF02774(Semialdhyde_dhC) | 5 | LEU A 70VAL A 139ILE A 120VAL A 89ILE A 91 | None | 0.89A | 2f8gB-1vknA:undetectable | 2f8gB-1vknA:17.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wac | P2 PROTEIN (Pseudomonasvirus phi6) |
PF00680(RdRP_1) | 6 | LEU A 252GLY A 35ALA A 36PRO A 261VAL A 260ILE A 258 | None | 1.42A | 2f8gB-1wacA:undetectable | 2f8gB-1wacA:10.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wdt | ELONGATION FACTOR GHOMOLOG (Thermusthermophilus) |
PF00009(GTP_EFTU)PF00679(EFG_C)PF03764(EFG_IV)PF14492(EFG_II) | 5 | ALA A 237VAL A 213GLY A 231VAL A 208ILE A 212 | None | 0.82A | 2f8gB-1wdtA:undetectable | 2f8gB-1wdtA:8.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wsv | AMINOMETHYLTRANSFERASE (Homo sapiens) |
PF01571(GCV_T)PF08669(GCV_T_C) | 5 | LEU A 152VAL A 192GLY A 166VAL A 207ILE A 205 | LEU A 152 ( 0.6A)VAL A 192 ( 0.6A)GLY A 166 ( 0.0A)VAL A 207 ( 0.6A)ILE A 205 ( 0.4A) | 0.80A | 2f8gB-1wsvA:undetectable | 2f8gB-1wsvA:15.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1yhn | RAS-RELATED PROTEINRAB-7 (Homo sapiens) |
PF00071(Ras) | 5 | LEU A 46VAL A 11ILE A 169VAL A 162ILE A 61 | None | 0.87A | 2f8gB-1yhnA:undetectable | 2f8gB-1yhnA:18.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b3x | IRON-RESPONSIVEELEMENT BINDINGPROTEIN 1 (Homo sapiens) |
PF00330(Aconitase)PF00694(Aconitase_C) | 6 | LEU A 669GLY A 672ALA A 770VAL A 795GLY A 775PRO A 787 | None | 1.17A | 2f8gB-2b3xA:undetectable | 2f8gB-2b3xA:7.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bih | NITRATE REDUCTASE[NADPH] (Ogataea angusta) |
PF00174(Oxidored_molyb)PF03404(Mo-co_dimer) | 5 | LEU A 256GLY A 178ALA A 180VAL A 107ILE A 109 | None | 0.87A | 2f8gB-2bihA:undetectable | 2f8gB-2bihA:12.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bii | NITRATE REDUCTASE[NADPH] (Ogataea angusta) |
PF00174(Oxidored_molyb)PF03404(Mo-co_dimer) | 5 | LEU A 256GLY A 178ALA A 180VAL A 107ILE A 109 | None | 0.80A | 2f8gB-2biiA:undetectable | 2f8gB-2biiA:13.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cun | PHOSPHOGLYCERATEKINASE (Pyrococcushorikoshii) |
PF00162(PGK) | 5 | LEU A 316ILE A 376GLY A 357VAL A 343ILE A 347 | None | 0.90A | 2f8gB-2cunA:undetectable | 2f8gB-2cunA:14.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2e2n | HEXOKINASE (Sulfurisphaeratokodaii) |
PF01869(BcrAD_BadFG) | 5 | GLY A 27ASP A 20ILE A 4GLY A 6VAL A 7 | None | 0.91A | 2f8gB-2e2nA:undetectable | 2f8gB-2e2nA:15.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fb5 | HYPOTHETICALMEMBRANE SPANNINGPROTEIN (Bacillus cereus) |
PF02457(DisA_N)PF10372(YojJ) | 5 | LEU A 183ALA A 94VAL A 138ILE A 126ILE A 96 | None | 0.89A | 2f8gB-2fb5A:undetectable | 2f8gB-2fb5A:14.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2fmb | EQUINE INFECTIOUSANEMIA VIRUSPROTEASE (Equineinfectiousanemia virus) |
PF00077(RVP) | 6 | ASP A 25GLY A 27ALA A 28VAL A 32GLY A 54ILE A 89 | LP1 A 201 (-2.3A)LP1 A 201 (-3.8A)LP1 A 201 (-3.5A)NoneLP1 A 201 (-3.6A)LP1 A 201 (-4.2A) | 0.90A | 2f8gB-2fmbA:15.0 | 2f8gB-2fmbA:34.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2fmb | EQUINE INFECTIOUSANEMIA VIRUSPROTEASE (Equineinfectiousanemia virus) |
PF00077(RVP) | 11 | LEU A 23ASP A 25GLY A 27ALA A 28VAL A 32ILE A 53GLY A 55VAL A 56PRO A 86VAL A 87ILE A 89 | NoneLP1 A 201 (-2.3A)LP1 A 201 (-3.8A)LP1 A 201 (-3.5A)NoneLP1 A 201 (-4.6A)LP1 A 201 (-3.4A)LP1 A 201 ( 4.7A)LP1 A 201 (-3.9A)LP1 A 201 ( 4.9A)LP1 A 201 (-4.2A) | 0.50A | 2f8gB-2fmbA:15.0 | 2f8gB-2fmbA:34.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g28 | PYRUVATEDEHYDROGENASE E1COMPONENT (Escherichiacoli) |
PF00456(Transketolase_N) | 5 | LEU A 565GLY A 573PRO A 594VAL A 516ILE A 518 | None | 0.74A | 2f8gB-2g28A:undetectable | 2f8gB-2g28A:8.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2h0i | THIOL:DISULFIDEINTERCHANGE PROTEINDSBG (Escherichiacoli) |
PF13098(Thioredoxin_2) | 5 | GLY A 14VAL A 7ILE A 17GLY A 32ILE A 10 | None | 0.88A | 2f8gB-2h0iA:undetectable | 2f8gB-2h0iA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2h39 | PROBABLEGALACTOSE-1-PHOSPHATE URIDYL TRANSFERASE (Arabidopsisthaliana) |
PF01087(GalP_UDP_transf)PF02744(GalP_UDP_tr_C) | 6 | ASP A 139ILE A 148GLY A 144PRO A 131VAL A 132ILE A 135 | None | 1.48A | 2f8gB-2h39A:undetectable | 2f8gB-2h39A:16.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2j4d | CRYPTOCHROME DASH (Arabidopsisthaliana) |
PF00875(DNA_photolyase)PF03441(FAD_binding_7) | 6 | LEU A 130GLY A 135ALA A 136PRO A 70VAL A 71ILE A 43 | None | 1.10A | 2f8gB-2j4dA:undetectable | 2f8gB-2j4dA:12.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ji9 | OXALYL-COADECARBOXYLASE (Oxalobacterformigenes) |
PF00205(TPP_enzyme_M)PF02775(TPP_enzyme_C)PF02776(TPP_enzyme_N) | 6 | GLY A 221ALA A 224VAL A 330ILE A 305VAL A 237ILE A 233 | ADP A1556 (-3.3A)NoneNoneNoneNoneNone | 1.50A | 2f8gB-2ji9A:undetectable | 2f8gB-2ji9A:10.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2n5u | TSR0524 PROTEIN (Thermosynechococcuselongatus) |
PF11061(DUF2862) | 5 | GLY A 64ASP A 2ILE A 30GLY A 28VAL A 27 | None | 0.86A | 2f8gB-2n5uA:undetectable | 2f8gB-2n5uA:22.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2oi6 | BIFUNCTIONAL PROTEINGLMU (Escherichiacoli) |
PF00132(Hexapep)PF12804(NTP_transf_3) | 5 | LEU A 133GLY A 138ILE A 152VAL A 131ILE A 168 | None | 0.87A | 2f8gB-2oi6A:undetectable | 2f8gB-2oi6A:12.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pfk | 6-PHOSPHOFRUCTOKINASE ISOZYME I (Escherichiacoli) |
PF00365(PFK) | 6 | LEU A 122GLY A 15ASP A 12VAL A 57VAL A 98ILE A 100 | None | 1.08A | 2f8gB-2pfkA:undetectable | 2f8gB-2pfkA:16.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q0l | THIOREDOXINREDUCTASE (Helicobacterpylori) |
PF07992(Pyr_redox_2) | 5 | ALA A 5VAL A 84ILE A 108GLY A 8ILE A 93 | NoneNoneNoneFAD A 400 (-3.2A)None | 0.91A | 2f8gB-2q0lA:undetectable | 2f8gB-2q0lA:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q50 | GLYOXYLATEREDUCTASE/HYDROXYPYRUVATE REDUCTASE (Homo sapiens) |
PF00389(2-Hacid_dh)PF02826(2-Hacid_dh_C) | 5 | GLY A 72VAL A 63ILE A 78GLY A 54ILE A 67 | None | 0.79A | 2f8gB-2q50A:undetectable | 2f8gB-2q50A:16.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qvw | GLP_546_48378_50642 (Giardiaintestinalis) |
PF00636(Ribonuclease_3)PF02170(PAZ) | 5 | GLY A 422ILE A 566VAL A 571PRO A 574VAL A 575 | None | 0.88A | 2f8gB-2qvwA:undetectable | 2f8gB-2qvwA:9.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qzx | CANDIDAPEPSIN-5 (Candidaalbicans) |
PF00026(Asp) | 5 | ASP A 32GLY A 34ASP A 37ILE A 82ILE A 123 | None | 0.90A | 2f8gB-2qzxA:7.2 | 2f8gB-2qzxA:17.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r94 | 2-KETO-3-DEOXY-(6-PHOSPHO-)GLUCONATEALDOLASE (Thermoproteustenax) |
PF00701(DHDPS) | 6 | LEU A 225ASP A 236VAL A 232ILE A 237VAL A 202ILE A 228 | None | 1.40A | 2f8gB-2r94A:undetectable | 2f8gB-2r94A:15.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ri6 | 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE HYDROLASE (Paraburkholderiaxenovorans) |
PF12697(Abhydrolase_6) | 6 | LEU A 283GLY A 63ALA A 62GLY A 57VAL A 56VAL A 279 | None | 1.10A | 2f8gB-2ri6A:undetectable | 2f8gB-2ri6A:16.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ri6 | 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE HYDROLASE (Paraburkholderiaxenovorans) |
PF12697(Abhydrolase_6) | 6 | LEU A 283GLY A 63ALA A 62GLY A 57VAL A 279ILE A 280 | None | 0.96A | 2f8gB-2ri6A:undetectable | 2f8gB-2ri6A:16.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2rkf | PROTEASE RETROPEPSIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | LEU A 23ASP A 25GLY A 27ALA A 28ASP A 30PRO A 81ILE A 84 | NoneAB1 A 501 (-2.4A)AB1 A 501 (-3.9A)AB1 A 501 (-3.5A)AB1 A 501 (-3.8A)AB1 A 501 (-4.2A)AB1 A 501 ( 4.2A) | 0.65A | 2f8gB-2rkfA:20.6 | 2f8gB-2rkfA:81.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2rkf | PROTEASE RETROPEPSIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | LEU A 23ASP A 25GLY A 27ALA A 28GLY A 49PRO A 81ILE A 84 | NoneAB1 A 501 (-2.4A)AB1 A 501 (-3.9A)AB1 A 501 (-3.5A)AB1 A 501 (-3.5A)AB1 A 501 (-4.2A)AB1 A 501 ( 4.2A) | 0.43A | 2f8gB-2rkfA:20.6 | 2f8gB-2rkfA:81.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2rsp | RSV PROTEASE (Rous sarcomavirus) |
PF00077(RVP) | 5 | LEU A 35ASP A 37GLY A 39ALA A 40ILE A 108 | None | 0.51A | 2f8gB-2rspA:12.6 | 2f8gB-2rspA:32.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2v0j | BIFUNCTIONAL PROTEINGLMU (Haemophilusinfluenzae) |
PF00132(Hexapep)PF12804(NTP_transf_3) | 5 | LEU A 332GLY A 345VAL A 367ILE A 378ILE A 350 | None | 0.86A | 2f8gB-2v0jA:undetectable | 2f8gB-2v0jA:13.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yb6 | UBIQUITIN-CONJUGATING ENZYME E2 B (Homo sapiens) |
PF00179(UQ_con) | 5 | GLY A 26ALA A 38VAL A 70ILE A 109ILE A 57 | None | 0.87A | 2f8gB-2yb6A:undetectable | 2f8gB-2yb6A:19.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z6i | TRANS-2-ENOYL-ACPREDUCTASE II (Streptococcuspneumoniae) |
PF03060(NMO) | 6 | LEU A 38GLY A 30ALA A 29VAL A 68ILE A 55VAL A 91 | None | 1.43A | 2f8gB-2z6iA:undetectable | 2f8gB-2z6iA:18.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zuk | ALPHA-AMINO-EPSILON-CAPROLACTAM RACEMASE (Achromobacterobae) |
PF00202(Aminotran_3) | 5 | LEU A 395GLY A 392ASP A 210GLY A 435VAL A 385 | None | 0.92A | 2f8gB-2zukA:undetectable | 2f8gB-2zukA:13.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zxo | SINGLE-STRANDED DNASPECIFIC EXONUCLEASERECJ (Thermusthermophilus) |
PF01368(DHH)PF02272(DHHA1) | 5 | LEU A 92GLY A 187ALA A 188PRO A 207ILE A 91 | None | 0.92A | 2f8gB-2zxoA:undetectable | 2f8gB-2zxoA:10.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zxq | ENDO-ALPHA-N-ACETYLGALACTOSAMINIDASE (Bifidobacteriumlongum) |
PF12905(Glyco_hydro_101)PF17451(Glyco_hyd_101C) | 6 | LEU A 563GLY A 515VAL A 471GLY A 613VAL A 473ILE A 517 | None | 1.46A | 2f8gB-2zxqA:undetectable | 2f8gB-2zxqA:5.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3c4n | UNCHARACTERIZEDPROTEIN DR_0571 (Deinococcusradiodurans) |
PF01266(DAO) | 5 | LEU A 370GLY A 200VAL A 40VAL A 230ILE A 228 | None | 0.81A | 2f8gB-3c4nA:undetectable | 2f8gB-3c4nA:12.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3d5t | MALATE DEHYDROGENASE (Burkholderiapseudomallei) |
PF00056(Ldh_1_N)PF02866(Ldh_1_C) | 6 | LEU A 165ALA A 199GLY A 203PRO A 175VAL A 176ILE A 179 | None | 1.44A | 2f8gB-3d5tA:undetectable | 2f8gB-3d5tA:16.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3d79 | PUTATIVEUNCHARACTERIZEDPROTEIN PH0734 (Pyrococcushorikoshii) |
PF01472(PUA)PF09183(DUF1947) | 6 | LEU A 101GLY A 95ALA A 96VAL A 106ILE A 111ILE A 100 | None | 1.08A | 2f8gB-3d79A:undetectable | 2f8gB-3d79A:20.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dj4 | BIFUNCTIONAL PROTEINGLMU (Mycobacteriumtuberculosis) |
PF00132(Hexapep)PF12804(NTP_transf_3) | 6 | LEU A 349ALA A 319ASP A 317ILE A 298VAL A 322ILE A 331 | None | 1.44A | 2f8gB-3dj4A:undetectable | 2f8gB-3dj4A:10.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dmo | CYTIDINE DEAMINASE (Burkholderiapseudomallei) |
PF00383(dCMP_cyt_deam_1) | 5 | ALA A 58GLY A 27VAL A 26VAL A 105ILE A 75 | None | 0.89A | 2f8gB-3dmoA:undetectable | 2f8gB-3dmoA:21.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ecd | SERINEHYDROXYMETHYLTRANSFERASE 2 (Burkholderiapseudomallei) |
PF00464(SHMT) | 6 | LEU A 295GLY A 216ALA A 215PRO A 370VAL A 294ILE A 291 | None | 1.32A | 2f8gB-3ecdA:undetectable | 2f8gB-3ecdA:14.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g7r | PUTATIVETRANSCRIPTIONALREGULATOR (Streptomycescoelicolor) |
PF00440(TetR_N) | 5 | ALA A 167VAL A 99GLY A 186VAL A 94ILE A 98 | NoneNoneNoneNoneEDO A 960 ( 4.8A) | 0.89A | 2f8gB-3g7rA:undetectable | 2f8gB-3g7rA:17.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gf7 | GLUTACONYL-COADECARBOXYLASESUBUNIT A ([Clostridium]symbiosum) |
PF01039(Carboxyl_trans) | 5 | LEU A 148GLY A 191ALA A 213GLY A 256ILE A 189 | None | 0.83A | 2f8gB-3gf7A:undetectable | 2f8gB-3gf7A:10.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gh8 | IODOTYROSINEDEHALOGENASE 1 (Mus musculus) |
PF00881(Nitroreductase) | 5 | LEU A 256GLY A 218ILE A 116GLY A 120ILE A 190 | None | 0.85A | 2f8gB-3gh8A:undetectable | 2f8gB-3gh8A:20.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gvc | PROBABLE SHORT-CHAINTYPEDEHYDROGENASE/REDUCTASE (Mycobacteriumtuberculosis) |
PF13561(adh_short_C2) | 5 | GLY A 137ALA A 138GLY A 112VAL A 113ILE A 182 | None | 0.91A | 2f8gB-3gvcA:undetectable | 2f8gB-3gvcA:16.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hdy | UDP-GALACTOPYRANOSEMUTASE (Deinococcusradiodurans) |
PF03275(GLF)PF13450(NAD_binding_8) | 5 | GLY A 38ALA A 37VAL A 237VAL A 55ILE A 57 | FAD A 450 (-3.3A)NoneNoneNoneNone | 0.88A | 2f8gB-3hdyA:undetectable | 2f8gB-3hdyA:13.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3him | PROBABLETRANSCRIPTIONALREGULATOR (Rhodococcusjostii) |
PF00440(TetR_N) | 6 | GLY A 147ALA A 89ASP A 91ILE A 87VAL A 139ILE A 143 | None | 1.47A | 2f8gB-3himA:undetectable | 2f8gB-3himA:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i4o | TRANSLATIONINITIATION FACTORIF-1 (Mycobacteriumtuberculosis) |
PF01176(eIF-1a) | 6 | LEU A 27GLY A 66ALA A 35VAL A 14ILE A 48ILE A 25 | None | 1.15A | 2f8gB-3i4oA:undetectable | 2f8gB-3i4oA:21.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3iay | DNA POLYMERASE DELTACATALYTIC SUBUNIT (Saccharomycescerevisiae) |
PF00136(DNA_pol_B)PF03104(DNA_pol_B_exo1) | 5 | ASP A 976GLY A 975ALA A 971ILE A 811GLY A 598 | None | 0.91A | 2f8gB-3iayA:undetectable | 2f8gB-3iayA:8.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3j7a | 40S RIBOSOMALPROTEIN ES6 (Plasmodiumfalciparum) |
PF01092(Ribosomal_S6e) | 5 | LEU H 111GLY H 55ILE H 101GLY H 103ILE H 52 | None G A 160 ( 3.9A)NoneNoneNone | 0.87A | 2f8gB-3j7aH:undetectable | 2f8gB-3j7aH:16.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jvd | TRANSCRIPTIONALREGULATORS (Corynebacteriumglutamicum) |
PF13377(Peripla_BP_3) | 5 | LEU A 235GLY A 265GLY A 278VAL A 275VAL A 261 | None | 0.89A | 2f8gB-3jvdA:undetectable | 2f8gB-3jvdA:16.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lu2 | LMO2462 PROTEIN (Listeriamonocytogenes) |
PF01244(Peptidase_M19) | 6 | GLY A 154ALA A 138ASP A 140GLY A 129VAL A 128PRO A 109 | None | 1.17A | 2f8gB-3lu2A:undetectable | 2f8gB-3lu2A:14.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mgl | SULFATE PERMEASEFAMILY PROTEIN (Vibrio cholerae) |
PF01740(STAS) | 5 | LEU A 475VAL A 532GLY A 522VAL A 505ILE A 507 | None | 0.92A | 2f8gB-3mglA:undetectable | 2f8gB-3mglA:23.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ALA A 28VAL A 32GLY A 48PRO A 81VAL A 82ILE A 84 | None | 0.96A | 2f8gB-3mwsA:19.7 | 2f8gB-3mwsA:78.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 11 | LEU A 23ASP A 25GLY A 27ALA A 28ASP A 30VAL A 32ILE A 47GLY A 49PRO A 81VAL A 82ILE A 84 | None | 0.33A | 2f8gB-3mwsA:19.7 | 2f8gB-3mwsA:78.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qc5 | PLATELET BINDINGPROTEIN GSPB (Streptococcusgordonii) |
no annotation | 5 | GLY X 390ALA X 389ASP X 258VAL X 297ILE X 264 | None | 0.70A | 2f8gB-3qc5X:undetectable | 2f8gB-3qc5X:15.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rha | PUTRESCINE OXIDASE (Paenarthrobacteraurescens) |
PF01593(Amino_oxidase) | 6 | GLY A 441ALA A 22VAL A 10ILE A 448VAL A 13ILE A 12 | NoneNoneNoneNoneFDA A 483 (-4.8A)None | 1.46A | 2f8gB-3rhaA:undetectable | 2f8gB-3rhaA:13.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3slz | GAG-PRO-POLPOLYPROTEIN (Murine leukemiavirus) |
PF00077(RVP) | 5 | ASP A 32GLY A 34ALA A 35VAL A 39PRO A 89 | 3TL A 126 (-2.4A)3TL A 126 (-3.1A)3TL A 126 ( 4.0A)None3TL A 126 (-4.0A) | 0.60A | 2f8gB-3slzA:11.2 | 2f8gB-3slzA:25.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3slz | GAG-PRO-POLPOLYPROTEIN (Murine leukemiavirus) |
PF00077(RVP) | 6 | LEU A 30ASP A 32GLY A 34ALA A 35VAL A 39GLY A 56 | None3TL A 126 (-2.4A)3TL A 126 (-3.1A)3TL A 126 ( 4.0A)None3TL A 126 (-3.4A) | 0.45A | 2f8gB-3slzA:11.2 | 2f8gB-3slzA:25.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3t2y | SULFIDE-QUINONEREDUCTASE, PUTATIVE (Acidithiobacillusferrooxidans) |
PF07992(Pyr_redox_2) | 5 | LEU A 7GLY A 106ALA A 303GLY A 281ILE A 103 | FAD A 500 (-4.7A)FAD A 500 (-3.1A)NoneNoneNone | 0.74A | 2f8gB-3t2yA:undetectable | 2f8gB-3t2yA:12.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3t3c | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | LEU A 23ASP A 25GLY A 27ALA A 28ASP A 30VAL A 32PRO A 81 | SO4 A 101 (-4.2A)017 A 201 (-2.6A)017 A 201 (-3.4A)017 A 201 (-3.5A)017 A 201 (-4.2A)NoneNone | 0.60A | 2f8gB-3t3cA:18.1 | 2f8gB-3t3cA:73.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3t3c | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 8 | LEU A 23ASP A 25GLY A 27ALA A 28VAL A 32ILE A 47GLY A 49PRO A 81 | SO4 A 101 (-4.2A)017 A 201 (-2.6A)017 A 201 (-3.4A)017 A 201 (-3.5A)NoneNone017 A 201 (-4.0A)None | 0.82A | 2f8gB-3t3cA:18.1 | 2f8gB-3t3cA:73.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tqs | RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE A (Coxiellaburnetii) |
PF00398(RrnaAD) | 5 | GLY A 105VAL A 25GLY A 44VAL A 20ILE A 24 | None | 0.84A | 2f8gB-3tqsA:undetectable | 2f8gB-3tqsA:20.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ttp | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 8 | LEU A 23ASP A 25GLY A 27ALA A 28ASP A 30GLY A 49PRO A 81ILE A 84 | None017 A 201 (-2.6A)017 A 201 (-3.6A)017 A 201 (-3.4A)017 A 201 (-4.6A)017 A 201 (-3.0A)017 A 201 (-4.1A)017 A 201 (-4.7A) | 0.49A | 2f8gB-3ttpA:19.4 | 2f8gB-3ttpA:75.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3u7s | POL POLYPROTEIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | LEU A 23ASP A 25GLY A 27ALA A 28ASP A 30ILE A 47PRO A 81 | None017 A 202 ( 2.5A)017 A 201 ( 3.5A)017 A 201 (-3.4A)017 A 201 ( 4.0A)017 A 202 (-3.6A)017 A 202 (-4.0A) | 0.65A | 2f8gB-3u7sA:19.6 | 2f8gB-3u7sA:75.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3u7s | POL POLYPROTEIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | LEU A 23ASP A 25GLY A 27ALA A 28ILE A 47GLY A 49PRO A 81 | None017 A 202 ( 2.5A)017 A 201 ( 3.5A)017 A 201 (-3.4A)017 A 202 (-3.6A)017 A 202 (-2.9A)017 A 202 (-4.0A) | 0.52A | 2f8gB-3u7sA:19.6 | 2f8gB-3u7sA:75.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3uhl | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | LEU A 23ASP A 25GLY A 27ALA A 28PRO A 81VAL A 82 | None | 0.32A | 2f8gB-3uhlA:15.8 | 2f8gB-3uhlA:79.80 |